Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,132
Closed -$85K 1609
2023
Q3
$85K Buy
+12,132
New +$112K 0.01% 849
2022
Q3
Sell
-16,238
Closed -$349K 1763
2022
Q2
$349K Buy
+16,238
New +$450K 0.03% 515
2021
Q2
Sell
-4,019
Closed -$274K 1554
2021
Q1
$274K Buy
+4,019
New +$312K 0.02% 875
2019
Q4
Sell
-9,834
Closed -$222K 1474
2019
Q3
$222K Buy
+9,834
New +$272K 0.02% 908
2019
Q2
Sell
-35,430
Closed -$1.12M 1482
2019
Q1
$1.12M Buy
+35,430
New +$1.03M 0.06% 280
2018
Q3
Sell
-23,360
Closed -$286K 1590
2018
Q2
$286K Buy
23,360
+622
+3% +$7.13K 0.02% 1189
2018
Q1
$181K Buy
+22,738
New +$140K 0.01% 1398

Other funds holding CDNA

Virtu Financial's CDNA Position: Q4 2023 in Review

Virtu Financial sold out of CareDx (CDNA) in Q4 2023, closing a stake of 12,132 shares — an estimated $85K sold.

Virtu Financial first reported a position in CDNA in Q1 2018 and held it in 7 quarters. The position peaked at $1.12M in Q1 2019. 147 funds tracked by Wall St. Rank hold CDNA as of Q4 2023.

  • Virtu Financial reported no remaining CareDx position as of Q4 2023 after selling out during the quarter.
  • Virtu Financial sold 12,132 CareDx shares in Q4 2023, an estimated $85K.
  • Virtu Financial first reported a position in CareDx in Q1 2018 and held it in 7 quarters.
  • Virtu Financial's CareDx position peaked at $1.12M in Q1 2019.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.